Topical mupirocin 2% ointment for diagnosis of Zoon's balanitis and monotherapy of balanitis circumscripta plasmacellularis

Cohen, Philip R.

doi:10.1111/ijd.14368

Cited by 8 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…CosmoDerma 2022;2:40. treatment with topical mupirocin. [5] Our patient also noticed significant improvement with mupirocin, which resulted in the continuation of the treatment on his own. Erythematous lesions in the glans penis and prepuce might require a histopathological examination to make a diagnosis.…”

Section: Declaration Of Patient Consentsupporting

confidence: 54%

Resolution of Zoon’s balanitis following topical mupirocin application: A case report

Narayanan

Balasundaram

Thappa

2022

CSDM

View full text Add to dashboard Cite

show abstract

Section: Declaration Of Patient Consentsupporting

confidence: 54%

Resolution of Zoon’s balanitis following topical mupirocin application: A case report

Narayanan

Balasundaram

Thappa

2022

CSDM

View full text Add to dashboard Cite

show abstract

“… Hygiene measures Management of underlying dermatoses 60 Circumcision—this has been reported to lead to the resolution of lesions 62 (1,C) Topical steroid preparations—with or without added antibacterial agents, for example Clobetasone butyrate with Nystatin and Oxytetracycline cream, applied once or twice daily 63 . (2,D) Antibacterial creams like mupirocin 2% ointment applied twice daily 64‐66 (2,D) Topical calcineurin inhibitors 67,68 (2,D) can be efficacious (pimecrolimus applied twice daily). There is still concern about the risk of malignancy 55 in case of continuous long‐term use.…”

Section: Management Of Specific Conditionsmentioning

confidence: 99%

2022 European guideline for the management of balanoposthitis

Edwards¹,

Bunker

Snoek

et al. 2023

Acad Dermatol Venereol

View full text Add to dashboard Cite

Background This guideline is an update to the 2014 edition of the European guideline for the management of balanoposthitis. Balanoposthitis describes inflammation of the glans penis and prepuce and is caused by a range of disparate conditions including infection, dermatoses and premalignancy. Objective The main objectives of this guideline are to aid recognition of the symptoms and signs and complications of penile skin conditions and to offer recommendations on the diagnostic tests and treatment for a selected group of these conditions. Methods The previous guideline was updated following a literature review and priority was given to randomized controlled trial and systematic review evidence. Results The updated guideline includes amended management for infective balanitis to provide clear guidance for Group A streptococcal infections, management of on going Lichen sclerosus (to include circumcision and supportive management to reduce the recurrence of genital herpes and warts), additional regimens for Zoonoid change, use of calcineurin inhibitors in management and risk of premalignancy and change of nomenclaturefrom Premalignant conditions to Penile Intraepithelial neoplasia (PeIN). Conclusion Balanoposthitis has a widerange of causes high quality evidence specific to the management of penile disease is not available for all the conditions described.

show abstract

“…Topical mupirocin 2% could be first line of therapy but relapse is frequent after suspension. 3,4 Topical corticosteroids are useful to treat the acute phase of ZB but they cannot be employed for a long period of time because of the local side effects.…”

mentioning

confidence: 99%

Topical cyclosporine 5% cream in Zoon's balanitis resistant to other therapies: A case report

Giorgio

Briatico

Licata

et al. 2021

Dermatologic Therapy

View full text Add to dashboard Cite

Zoon's balanitis (ZB), or balanitis circumscripta plasmacellularis, is a nonvenereal disease, characterized by a chronic, idiopathic, and benign inflammation of genital mucosa. It affects glans of men aged 20-90 years and often uncircumcised. The diagnostic criteria are:(a) presence of shiny, erythematous plaques on glans, prepuce or both, for more than 3 months; (b) poor response to topical therapies (minimum 4 weeks); and (c) absence of concurrent infections. 1 The man-

show abstract

Topical mupirocin 2% ointment for diagnosis of Zoon's balanitis and monotherapy of balanitis circumscripta plasmacellularis

Cited by 8 publications

References 7 publications

Resolution of Zoon’s balanitis following topical mupirocin application: A case report

Resolution of Zoon’s balanitis following topical mupirocin application: A case report

2022 European guideline for the management of balanoposthitis

Topical cyclosporine 5% cream in Zoon's balanitis resistant to other therapies: A case report

Contact Info

Product

Resources

About